Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection

Ya-Nan Li,Zhong-Wei Wang,Fan Li,Ling-Hong Zhou,Yan-Shan Jiang,Yao Yu,Hui-Hui Ma,Li-Ping Zhu,Jie-Ming Qu,Xin-Ming Jia
DOI: https://doi.org/10.1038/s41467-022-31723-4
IF: 16.6
2022-07-14
Nature Communications
Abstract:Cryptococcosis is a potentially lethal disease that is primarily caused by the fungus Cryptococcus neoformans , treatment options for cryptococcosis are limited. Here, we show glucuronoxylomannan, the major polysaccharide component of C. neoformans , induces the recruitment of neutrophilic myeloid-derived suppressor cells in mice and patients with cryptococcosis. Depletion of neutrophilic myeloid-derived suppressor cells enhances host defense against C. neoformans infection. We identify C-type lectin receptor-2d recognizes glucuronoxylomannan to potentiate the immunosuppressive activity of neutrophilic myeloid-derived suppressor cells by initiating p38-mediated production of the enzyme arginase-1, which inhibits T-cell mediated antifungal responses. Notably, pharmacological inhibition of arginase-1 expression by a specific inhibitor of p38, SB202190, or an orally available receptor tyrosine kinase inhibitor, vandetanib, significantly enhances T-cell mediated antifungal responses against cryptococcosis. These data reveal a crucial suppressive role of neutrophilic myeloid-derived suppressor cells during cryptococcosis and highlight a promising immunotherapeutic application by inhibiting arginase-1 production to combat infectious diseases.
multidisciplinary sciences
What problem does this paper attempt to address?